Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$11.7M
35M shares
52-week range
$0.31 – $1.56
1% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
Borrow rate
16.35%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $3.5M | $2.9M |
| Cost of revenue | $0 | $0 | $0 | $0 | $2.7M | $2.3M |
| Gross profit | $0 | $0 | $0 | $0 | $811.2K | $592.9K |
| Gross margin | — | — | — | — | 23.0% | 20.4% |
| R&D | $0 | $0 | $0 | $0 | $161.2K | $318.4K |
| Operating income | −$23.8K | −$3.3K | −$35.4K | −$1.8M | −$11.7M | −$18.3M |
| EBITDA | −$23.8K | $233.3K | $193.1K | $3.7M | −$2.2M | −$19.1M |
| Net income | −$23.8K | −$3.3K | −$35.4K | $403.8K | −$10.3M | −$18.0M |
| Net margin | — | — | — | — | -292.6% | -619.8% |
| EPS (diluted) | -0.00 | -0.00 | -0.00 | 0.07 | -0.54 | -4.02 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $3M | $-1.09 | $-1.09–$-1.09 | 1 |
| 2027 | $72M | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
OSR Health Inc is a healthcare holding company focused on biomedical technologies in health and wellness. Through its subsidiaries, the company engages in immuno-oncology, regenerative biologics, and medical device technologies to improve health outcomes across various countries.
www.osr-holdings.comNo one on the platform currently holds OSRH.
No tracked institution reports a position in OSRH as of their last filing.
No one on the platform has traded OSRH yet.
| $9M |
| — |
| EONREON Resources Inc | $0.47 | -2.06% | $23M | — |
| JVSAJV SPAC Acquisition Corp. Class A Ordinary Share | $3.64 | -65.98% | $28M | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$OSRH CEO promised no R/S and 10$/share 🤣🤣 well he lied! Postpone the meeting showed his bluff sorry folks move to something else! This is a scam company
View on StockTwits ↗$OSRH 0.1$ and under people just wait for the new date for meeting they postponed since the need to do a R/S 30-1 😉
View on StockTwits ↗$OSRH If this gets to 1$+ again, naked shorts will be panicking. The CVRs could explode in their face. 💥 Nice recipe for a short squeeze.
View on StockTwits ↗$OSRH This dudes gotta go on block . Just spews bullsh*t out his mouth
View on StockTwits ↗$OSRH Yes, this is how micro-capitalizations work, especially biotech... The last PR did not convince me at all to make a purchase... on the contrary... yes, it offers you more shares for long-term holding... on the other hand, those shares have to come from somewhere... so classic dilution...
View on StockTwits ↗$OSRH I’m at .59 cents. No worries. Will blow past a dollar very soon!!! They stated last week that they would not do a rs. That they will grow organically. Running out of time, load up!!!
View on StockTwits ↗$OSRH People keep treating big pre‑reverse‑split buys like “smart money”, but that’s not how microcaps work. Those blocks are almost always placed by the same financiers or related parties who are about to dump into the post‑split liquidity. They load size before the R/S to stabilize the price, control the book, and make the next dilution cycle easier. It’s not conviction, it’s mechanics. Multiple reverse splits, active ATM, equity lines, and death‑spiral financing all follow the same playbook: engineer the float, reset the price, and sell into the next wave. Calling those pre‑split buys bullish is just misunderstanding how the machine actually operates!!!
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.